BFA
ARMP icon

BlackRock Fund Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

BlackRock Fund Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Hold
6
– – ﹤0.01% 4242
2016
Q3 		$1K Buy
6
+1
+20% +$230 ﹤0.01% 4204
2016
Q2 		$1K Hold
5
– – ﹤0.01% 4259
2016
Q1 		$3K Buy
5
+1
+25% +$513 ﹤0.01% 4159
2015
Q4 		$2K Buy
+4
New +$3.06K ﹤0.01% 4284

Other funds holding ARMP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

BlackRock Fund Advisors's ARMP Position: Q4 2016 in Review

BlackRock Fund Advisors held its Armata Pharmaceuticals (ARMP) position steady in Q4 2016 at 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4242.

BlackRock Fund Advisors first reported a position in ARMP in Q4 2015 and has held it in 5 quarters since. The position peaked at $3K in Q1 2016. 15 funds tracked by Wall St. Rank hold ARMP as of Q4 2016.

  • BlackRock Fund Advisors held 6 shares of Armata Pharmaceuticals worth $0 as of Q4 2016.
  • BlackRock Fund Advisors left its Armata Pharmaceuticals share count unchanged in Q4 2016.
  • Armata Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4242 holding.
  • BlackRock Fund Advisors first reported a position in Armata Pharmaceuticals in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's Armata Pharmaceuticals position peaked at $3K in Q1 2016.
  • 15 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.